- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05423743
Ensayo INSPIRE para infecciones abdominales
El ensayo INSPIRE-ASP (Intelligent Stewardship Indicaciones para mejorar la selección empírica de antibióticos en tiempo real para pacientes) para infecciones abdominales (ABD)
The INSPIRE Abdominal Infection Trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine computerized physician order entry (CPOE) smart prompts providing the probability that a non-critically ill adult admitted with abdominal infection is infected with a resistant pathogen.
Note: enrolled "subjects" represent 102 individual HCA Healthcare hospitals that have been randomized into 92 clusters. Hospitals were grouped into the same randomization cluster if they shared campuses or antibiotic stewardship staff.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
Riverside, California, Estados Unidos, 92501
- Riverside Community Hospital
-
San Jose, California, Estados Unidos, 95124
- Good Samaritan Hospital
-
San Jose, California, Estados Unidos, 95116
- Regional Medical Center of San Jose
-
Thousand Oaks, California, Estados Unidos, 91362
- Los Robles Hospital & Medical Center
-
West Hills, California, Estados Unidos, 91307
- West Hills Hospital & Medical Center
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80012
- The Medical Center of Aurora
-
Englewood, Colorado, Estados Unidos, 80113
- Swedish Medical Center
-
Lone Tree, Colorado, Estados Unidos, 80124
- Sky Ridge Medical Center
-
Thornton, Colorado, Estados Unidos, 80229
- North Suburban Medical Center
-
-
Florida
-
Bradenton, Florida, Estados Unidos, 34209
- Blake Medical Center
-
Brandon, Florida, Estados Unidos, 33511
- Brandon Regional Hospital
-
Brooksville, Florida, Estados Unidos, 34613
- Oak Hill Hospital
-
Englewood, Florida, Estados Unidos, 34223
- Englewood Community Hospital
-
Fort Walton Beach, Florida, Estados Unidos, 32547
- Fort Walton Beach Medical Center
-
Ft. Pierce, Florida, Estados Unidos, 34950
- Lawnwood Regional Medical Center
-
Hudson, Florida, Estados Unidos, 34667
- Regional Medical Center of Bayonet Point
-
Jacksonville, Florida, Estados Unidos, 32216
- Memorial Hospital Jacksonville
-
Lake City, Florida, Estados Unidos, 32055
- Lake City Medical Center
-
Largo, Florida, Estados Unidos, 33770
- Largo Medical Center
-
Margate, Florida, Estados Unidos, 33063
- Northwest Medical Center
-
Miami, Florida, Estados Unidos, 33133
- Mercy Hospital
-
Miami, Florida, Estados Unidos, 33175
- Kendall Regional Medical Center
-
Orange Park, Florida, Estados Unidos, 32073
- Orange Park Medical Center
-
Oviedo, Florida, Estados Unidos, 32765
- Oviedo Medical Center
-
Panama City, Florida, Estados Unidos, 32405
- Gulf Coast Regional Medical Center
-
Port Charlotte, Florida, Estados Unidos, 33952
- Fawcett Memorial Hospital
-
Port Saint Lucie, Florida, Estados Unidos, 34952
- St. Lucie Medical Center
-
Sarasota, Florida, Estados Unidos, 34233
- Doctors Hospital of Sarasota
-
St. Petersburg, Florida, Estados Unidos, 33707
- Palms of Pasadena
-
St. Petersburg, Florida, Estados Unidos, 33709
- Northside Hospital
-
St. Petersburg, Florida, Estados Unidos, 33710
- St. Petersburg General Hospital
-
Sun City Center, Florida, Estados Unidos, 33573
- South Bay Hospital
-
Tallahassee, Florida, Estados Unidos, 32308
- Capital Regional Medical Center
-
Tampa, Florida, Estados Unidos, 33609
- HCA Florida South Tampa Hospital
-
Tampa, Florida, Estados Unidos, 33615
- HCA Florida West Tampa Hospital
-
Trinity, Florida, Estados Unidos, 34655
- Medical Center of Trinity
-
West Palm Beach, Florida, Estados Unidos, 33407
- JFK Medical Center - North Campus
-
-
Georgia
-
Dublin, Georgia, Estados Unidos, 31040
- Fairview Park Hospital
-
-
Idaho
-
Idaho Falls, Idaho, Estados Unidos, 83404
- Eastern Idaho Regional Medical Center
-
-
Kansas
-
Overland Park, Kansas, Estados Unidos, 66209
- Menorah Medical Center
-
Overland Park, Kansas, Estados Unidos, 66215
- Overland Park Regional Medical Center
-
Wichita, Kansas, Estados Unidos, 67214
- Wesley Medical Center
-
Wichita, Kansas, Estados Unidos, 67220
- Wesley Woodlawn Hospital & ER
-
-
Kentucky
-
Bowling Green, Kentucky, Estados Unidos, 41204
- TriStar Greenview Regional Hospital
-
-
Louisiana
-
Covington, Louisiana, Estados Unidos, 70433
- Lakeview Regional Medical Center
-
New Orleans, Louisiana, Estados Unidos, 70112
- Tulane Medical Center
-
-
Missouri
-
Independence, Missouri, Estados Unidos, 64057
- Centerpoint Medical Center
-
Kansas City, Missouri, Estados Unidos, 64132
- Research Medical Center
-
Lee's Summit, Missouri, Estados Unidos, 64063
- Lee's Summit Medical Center
-
-
Nevada
-
Las Vegas, Nevada, Estados Unidos, 89109
- Sunrise Hospital & Medical Center
-
Las Vegas, Nevada, Estados Unidos, 89109
- Southern Hills Hospital & Medical Center
-
-
South Carolina
-
Charleston, South Carolina, Estados Unidos, 29406
- Trident Medical Center
-
Myrtle Beach, South Carolina, Estados Unidos, 29572
- Grand Strand Medical Center
-
-
Tennessee
-
Chattanooga, Tennessee, Estados Unidos, 37404
- Parkridge Medical Center
-
Chattanooga, Tennessee, Estados Unidos, 37412
- Parkridge East Hospital
-
Dickson, Tennessee, Estados Unidos, 37055
- TriStar Horizon Medical Center
-
Hendersonville, Tennessee, Estados Unidos, 37075
- TriStar Hendersonville Medical Center
-
Nashville, Tennessee, Estados Unidos, 37203
- TriStar Centennial Medical Center
-
Nashville, Tennessee, Estados Unidos, 37211
- TriStar Southern Hills Medical Center
-
Smyrna, Tennessee, Estados Unidos, 37167
- TriStar StoneCrest Medical Center
-
-
Texas
-
Arlington, Texas, Estados Unidos, 76015
- Medical City Arlington
-
Austin, Texas, Estados Unidos, 78705
- St. David's Medical Center
-
Austin, Texas, Estados Unidos, 78758
- St. David's North Austin Medical Center
-
Brownsville, Texas, Estados Unidos, 78526
- Valley Regional Medical Center
-
Conroe, Texas, Estados Unidos, 77304
- HCA Houston Healthcare Conroe
-
Corpus Christi, Texas, Estados Unidos, 78412
- Corpus Christi Medical Center - Bay Area
-
Corpus Christi, Texas, Estados Unidos, 78412
- Corpus Christi Medical Center - Heart Hospital
-
Corpus Christi, Texas, Estados Unidos, 78412
- Corpus Christi Medical Center - Doctors Regional
-
Dallas, Texas, Estados Unidos, 75230
- Medical City Dallas
-
Denton, Texas, Estados Unidos, 76210
- Medical City Denton
-
El Paso, Texas, Estados Unidos, 79902
- Las Palmas Medical Center
-
El Paso, Texas, Estados Unidos, 79925
- Del Sol Medical Center
-
Fort Worth, Texas, Estados Unidos, 76104
- Medical City Fort Worth
-
Fort Worth, Texas, Estados Unidos, 76177
- Medical City Alliance
-
Frisco, Texas, Estados Unidos, 75034
- Medical City Frisco
-
Houston, Texas, Estados Unidos, 77082
- HCA Houston Healthcare West
-
Irving, Texas, Estados Unidos, 75039
- Medical City Las Colinas
-
Kingwood, Texas, Estados Unidos, 77339
- HCA Houston Healthcare Kingwood
-
Lewisville, Texas, Estados Unidos, 75057
- Medical City Lewisville
-
Live Oak, Texas, Estados Unidos, 78233
- Methodist Hospital Northeast
-
McAllen, Texas, Estados Unidos, 78503
- Rio Grande Regional Hospital Main Campus
-
McKinney, Texas, Estados Unidos, 75069
- Medical City McKinney
-
North Richland Hills, Texas, Estados Unidos, 76180
- Medical City North Hills
-
Pasadena, Texas, Estados Unidos, 77504
- HCA Houston Healthcare Southeast
-
Pearland, Texas, Estados Unidos, 77584
- HCA Houston Healthcare Pearland
-
Plano, Texas, Estados Unidos, 75075
- Medical City Plano
-
Round Rock, Texas, Estados Unidos, 78681
- St. David's Round Rock Medical Center
-
San Antonio, Texas, Estados Unidos, 78229
- Methodist Hospital
-
San Antonio, Texas, Estados Unidos, 78201
- Methodist Hospital Texsan
-
San Antonio, Texas, Estados Unidos, 78212
- Methodist Hospital Metropolitan
-
San Antonio, Texas, Estados Unidos, 78229
- Methodist Hospital | Specialty and Transplant
-
Texas City, Texas, Estados Unidos, 77591
- HCA Houston Healthcare Mainland
-
Weatherford, Texas, Estados Unidos, 76086
- Medical City Weatherford
-
Webster, Texas, Estados Unidos, 77598
- HCA Houston Healthcare Clear Lake
-
-
Utah
-
Ogden, Utah, Estados Unidos, 84405
- Ogden Regional Medical Center
-
-
Virginia
-
Blacksburg, Virginia, Estados Unidos, 24060
- LewisGale Hospital Montgomery
-
Pulaski, Virginia, Estados Unidos, 24301
- LewisGale Hospital Pulaski
-
Reston, Virginia, Estados Unidos, 20190
- Reston Hospital Center
-
Richmond, Virginia, Estados Unidos, 23229
- Henrico Doctors' Hospital
-
Richmond, Virginia, Estados Unidos, 23225
- CJW Medical Center (Chippenham & Johnston Willis Campuses)
-
Salem, Virginia, Estados Unidos, 24153
- LewisGale Medical Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Facility Inclusion Criteria:
- HCA Healthcare hospitals admitting adults for abdominal infection
- Facility use of MEDITECH as their electronic health record system
Facility Exclusion Criteria:
-
Note: unit of randomization is the hospital, however the computerized physician order entry (CPOE) alert intervention will calculate risk estimates for adults age >=18 admitted to non-intensive care unit wards and who are ordered to receive extended-spectrum antibiotics for abdominal infection.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Arm 1: Routine Care
Continuation of routine antibiotic stewardship strategies. |
Routine Antibiotic Stewardship Arm - Continuation of antibiotic stewardship activities in accordance with national standards. |
|
Comparador activo: Arm 2: INSPIRE Stewardship Bundle
Use of computerized physician order entry (CPOE) smart prompts, clinician feedback, and activities to support CPOE adoption (including education and alignment of CPOE workflows) to guide empiric choice of antibiotics for abdominal infection in the first 3 days of hospitalization. |
Quality improvement intervention that includes (1) computerized physician order entry (CPOE) decision support alert that provides physicians with patient-specific risk estimates for having an abdominal infection due to a multidrug-resistant organism (MDRO) and recommends standard spectrum antibiotics for low risk patients in the first 3 days of hospitalization; (2) clinician feedback reports, and (3) activities to support CPOE adoption (including education and alignment of CPOE workflows). Other antibiotic stewardship activities to continue in accordance with national standards. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Extended-Spectrum Days of Antibacterial Therapy (ES-DOT) Per Empiric Day
Periodo de tiempo: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Extended-spectrum days-of-therapy per empiric day is defined as the summed number of different extended-spectrum antibiotics received per patient each calendar day, beginning at admission. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. For example, 2 different extended-spectrum antibiotics administered at least once during each of the first 3 days would yield 6 days of extended-spectrum days-of-therapy. |
First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Vancomycin Days of Antibacterial Therapy Per Empiric Day
Periodo de tiempo: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Vancomycin days-of-therapy per empiric day is defined as the the number of days that vancomycin is received by a patient, averaged over the empiric period, and summed across all participants. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. |
First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
|
Antipseudomonal Antibiotic Days Of Therapy (ES-DOT) Per Empiric Day
Periodo de tiempo: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Antipseudomonal days-of-therapy per empiric day is defined as the summed number of different antipseudomonal antibiotics received per patient each calendar day, beginning at admission. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. For example, 2 different antipseudomonal antibiotics administered at least once during each of the first 3 days would yield 6 days of antipseudomonal days-of-therapy. |
First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Intensive Care Unit (ICU) Transfer [Safety Outcome 1]
Periodo de tiempo: Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
Days from hospital admission until transfer to ICU, if that occurs. If it doesn't occur, the number of days is censored (capped) at the patient's hospital discharge or at the end of data collection. Almost all patients will be discharged before the end of trial data collection. |
Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
|
Length-of-stay [Safety Outcome 2]
Periodo de tiempo: Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
Days from hospital admission until discharge. If the patient remains in the hospital at the end of the trial data collection, the number of days is censored (capped) at that time. Almost all patients will be discharged before the end of trial data collection. |
Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
|
Extended-Spectrum Days of Therapy With Inpatient Extended-Spectrum (ES) Antibiotic Treatment After Empiric Period
Periodo de tiempo: 12 months
|
The number of different ES antibiotics received each day, on hospital days ≥4 and ≤14. Note: this outcome is intended for a secondary manuscript |
12 months
|
|
Empiric and Total Antibiotic Costs
Periodo de tiempo: 12 months
|
Empiric and total antibiotic costs for abdominal infection during hospitalization. Note: this outcome is intended for a secondary manuscript. |
12 months
|
|
Incidence of Hospital-Onset C. Difficile
Periodo de tiempo: 12 months
|
Hospital-onset C. difficile positive tests (specimen obtained) on hospital days ≥4 and ≤14. Note: this outcome is intended for a secondary manuscript. |
12 months
|
|
Incidence of Hospital-Onset MDRO-Positive Cultures
Periodo de tiempo: 12 months
|
Newly-detected hospital-onset MDRO-positive cultures on hospital days ≥4 and ≤14. Includes total MDRO and specific MDRO subsets. Note: this outcome is intended for a secondary manuscript. |
12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Director de estudio: Shruti Gohil, MD, MPH, UC Irvine Division of Infectious Diseases
- Investigador principal: Susan Huang, MD, MPH, UC Irvine Division of Infectious Diseases
- Investigador principal: Richard Platt, MD, MS, Harvard Pilgrim Health Care Institute/Harvard Medical School
Publicaciones y enlaces útiles
Publicaciones Generales
- Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, Mauricio A, Sljivo S, Rahm R, Roemer K, Cooper WS, McLean LE, Nickolay NG, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith KN, Meador B, Froman A, Eibensteiner K, Hayden MK, Kubiak DW, Burks C, Burgess LH, Calderwood MS, Perlin JB, Platt R, Huang SS. Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal Infection: The INSPIRE 4 Cluster Randomized Clinical Trial. JAMA Surg. 2025 Jul 1;160(7):733-743. doi: 10.1001/jamasurg.2025.1108.
- Gohil SK, Avery TR, Kleinman K, Septimus E, Mauricio A, Sands KE, Varma N, Sljivo S, Roemer K, Cooper WS, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith-Sells KN, Hayden MK, Kubiak DW, Burks C, Platt R, Huang SS, Baker MA. Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary Analysis of the INSPIRE Cluster Randomized Trials. JAMA Netw Open. 2026 Jun 1;9(6):e2616611. doi: 10.1001/jamanetworkopen.2026.16611.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- PH000763B_ABD
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .